Global Information Lookup Global Information

Marion Merrell Dow information


Marion Merrell Dow
IndustryPharmaceutical
Founded1950 (Marion Laboratories)
1989 (Marion Merrell Dow)
Defunct1996
FateAcquired by Hoechst AG to create Hoechst Marion Roussel
SuccessorSanofi
HeadquartersKansas City, Missouri

Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.

The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including Cardizem which treats arrhythmias and high blood pressure, Carafate (an ulcer treatment), Gaviscon (an antacid), Seldane (a withdrawn antihistamine), Nicorette (anti-smoking gum) and Cepacol mouthwash.[1]

The company operating out of its headquarters at 9300 Ward Parkway was a springboard for its founder Ewing Marion Kauffman to start the Kansas City Royals baseball team.

  1. ^ Marion Merrell Dow, Inc., International Directory of Company Histories, Vol. 9. St. James Press, 1994 (reprinted on fundinguniverse.com)

and 21 Related for: Marion Merrell Dow information

Request time (Page generated in 0.8808 seconds.)

Marion Merrell Dow

Last Update:

Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996. The...

Word Count : 1670

Hoechst AG

Last Update:

Holdings. 1995 — Hoechst merges with Marion Merrell Dow of Kansas City, Missouri forming U.S. subsidiary Hoechst Marion Roussel (HMR). 1997 — Hoechst underwent...

Word Count : 686

Clomifene

Last Update:

acquired by Dow Chemical in 1980, and in 1989 Dow Chemical acquired 67 percent interest of Marion Laboratories, which was renamed Marion Merrell Dow. In 1995...

Word Count : 4853

Dicycloverine

Last Update:

given the drug. In 1994, the US Federal Trade Commission ordered Marion Merrell Dow, which had acquired Rugby Darby—the only generic manufacturer of dicycloverine...

Word Count : 1004

Ewing Kauffman

Last Update:

chairman, Marion Laboratories had revenues of $930 million in 1988, the year before it merged with Merrell Dow Pharmaceuticals to form Marion Merrell Dow. Kauffman...

Word Count : 1752

Genzyme

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 2013

Plomestane

Last Update:

irreversible aromatase inhibitor which was under development by Marion Merrell Dow/Hoechst Marion Russell (now Hoechst AG) as an antineoplastic agent for the...

Word Count : 281

1976 swine flu outbreak

Last Update:

the "duty to warn". In May, other vaccine manufacturers including Marion Merrell Dow, Parke-Davis, and Wyeth, were notified of indemnity problems by their...

Word Count : 1920

Sanofi

Last Update:

corporation Hoechst Marion Roussel, which itself was formed from the 1995 merger of Hoechst AG with Cassella, Roussel Uclaf, and Marion Merrell Dow. Hoechst AG...

Word Count : 8728

Sunovion

Last Update:

patented, purified active ingredients for expiring products. In 1993, Marion Merrell Dow, now a part of Sanofi, partnered with Sepracor to develop a purified...

Word Count : 637

Nicorette

Last Update:

Administration after a 34-month review. It was brought to the US market by Marion Merrell Dow under licence from AB Leo. In 2016, it was the third biggest selling...

Word Count : 3887

Edward Mabry

Last Update:

of the board of directors. Vicks became Richardson Merrell Inc. after merging with Marion Merrell Dow, and in 1985 was sold to Procter & Gamble, where it...

Word Count : 275

Pimagedine

Last Update:

to AGE inhibition from Rockefeller University. In 1989, Alteon and Marion Merrell Dow Inc (MMD) entered into a joint development program for pimagedine...

Word Count : 900

Chattem

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 685

Efanesoctocog alfa

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 300

Olipudase alfa

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 947

Roussel Uclaf

Last Update:

Laurent (October 2, 1997). "Hoechst Marion Roussel France touché par une des taxes Aubry". Les Échos. p. 8. Hoechst Marion Roussel France - ex-Roussel Uclaf...

Word Count : 1896

Chris Viehbacher

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 386

Olivier Brandicourt

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 659

Opendra Narayan

Last Update:

Kansas, where he was named Distinguished Professor and director of the Marion Merrell Dow Laboratory of Viral Pathogenesis. Narayan remained at Kansas until...

Word Count : 435

Cassella

Last Update:

Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Chattem Inc...

Word Count : 791

PDF Search Engine © AllGlobal.net